1.
Tahir Siddique, Sadaf Farzand, Marryam Khalid, Rizwan Ahmad, Kashif Aziz Ahmad, Muhammad Maqsood. Efficacy and Safety of Once-Weekly Semaglutide versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial. JHWCR [Internet]. 2025 Mar. 30 [cited 2026 Jul. 20];3(1):1-8. Available from: https://jhwcr.com/index.php/jhwcr/article/view/1948